POCN's Multiple Myeloma Center of Excellence - Multiple Myeloma: A POCN Center of Excellence

Multiple Myeloma Resources
Chosen by Advanced
Practice Providers

Clinical guidelines
Patient support and education resources
Research updates

Advances in Diagnosing and Treating High-Risk Multiple Myeloma

High-risk multiple myeloma (MM) is a challenging condition to diagnose and treat, requiring effective tools to identify patients and deliver targeted therapies....

CURATED BY: Jill N. Burke,
CNP, DipACLM

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Impact of Removing 24-Hour Urine Assessments from IMWG Criteria in Patients With MM Post-ASCT

Researchers of this study analyzed the impact of removing 24-hour urine (24HRU) assessments from International Myeloma Working Group (IMWG) response criteria for patients with multiple myeloma (MM) following autologous stem...

CURATED BY:
Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

Evaluating MRD Detection Methods in High-Risk Smoldering Multiple Myeloma: Sensitivity and Prognosis

This study evaluated the performance of mass spectrometry (MS), serum protein electrophoresis /immunofixation electrophoresis (IFE), and next-generation flow cytometry (NGF) for detecting minimal residual disease (MRD) in patients with high-risk...

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Multiparametric Flow Cytometry -Based MRD Assessment With DURAClone for Multiple Myeloma Post-ASCT

This study aimed to develop a multiparametric flow cytometry-based minimal residual disease (MRD) assessment protocol using the DURAClone method for patients with multiple myeloma (MM), particularly after autologous stem cell...

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Donna D. Catamero,

ANP-BC, OCN, CCRC
Associate Director, Myeloma Research, Icahn School of Medicine at Mount Sinai

Laura J. Zitella,

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Danielle Roberts,

MS, MMSc, PA-C
Associate Chief of Education, Winship Cancer Institute of Emory University

Provided by an unrestricted grant from

Company
Contact

Partner with Us
Ambassador Program

Advances in Diagnosing and Treating High-Risk Multiple Myeloma

Jill N. Burke,

Impact of Removing 24-Hour Urine Assessments from IMWG Criteria in Patients With MM Post-ASCT

Evaluating MRD Detection Methods in High-Risk Smoldering Multiple Myeloma: Sensitivity and Prognosis

Multiparametric Flow Cytometry -Based MRD Assessment With DURAClone for Multiple Myeloma Post-ASCT

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

Provided by an unrestricted grant from

© 2025 Point of Care Network, LLC. All Rights Reserved.

© 2025 Point of Care Network, LLC. All Rights Reserved.

Share